Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
Complete regulatory history of levothyroxine (Synthroid) across FDA, EMA, and global agencies, including approval timelines, label updates, and post-market surveillance findings.
Read clinical reviewA complete regulatory guide to Synthroid (levothyroxine) compounding legal status, FDA approval history, labeling requirements, and what compounded levothyroxine is and is not permitted under federal and state law.
Read clinical reviewA detailed comparison of how the FDA and EMA regulate Synthroid (levothyroxine), covering approval history, labeling requirements, bioequivalence standards, and post-market surveillance differences that affect patients and prescribers.
Read clinical reviewA detailed review of FDA Adverse Event Reporting System (FAERS) data for Synthroid (levothyroxine), including the most frequently reported safety signals, label changes, and clinical context for prescribers and patients.
Read clinical reviewSynthroid faced decades of legal battles over bioequivalence, FDA approval delays, and patent disputes. This article covers the full regulatory timeline, key lawsuits, and what they mean for patients on levothyroxine.
Read clinical reviewA comprehensive look at Synthroid (levothyroxine) FDA approval history, current labeling, post-market surveillance findings, and the next generation of thyroid hormone therapies in development.
Read clinical review